文献速递外周动脉疾病

外周动脉疾病4F兼容血管内材料:入路部位并发症与成本评估

4-French Compatible Endovascular Materials for Peripheral Artery Disease: Access Site Complications and Cost Evaluation.
PubMed 文献 · Ann Vasc Surg · 2025-10-31

该回顾性研究比较4F兼容材料与6F及以上标准鞘管在外周动脉疾病介入中的安全性与成本。110例患者分两组,术后并发症发生率无显著差异(2.2% vs 4.6%,P=0.6433),但4F组支架血管成形术器械与药物成本显著更低(€1,609.10 vs €2,102,P=0.03248)。

要点

  • 4F兼容材料术后并发症发生率与6F及以上鞘管无显著差异。
  • 4F组支架血管成形术器械与药物成本显著低于6F及以上组。
  • 6F及以上组额外成本€492.90,部分源于动脉闭合装置。

核心结论

  • 使用4F兼容血管内材料行血管成形术与6F及以上标准技术同样安全,且更具成本效益。

研究设计与样本

  • 回顾性分析,按介入时使用的鞘管尺寸将患者分为两组,共110例符合纳入标准,4F组45例,6F及以上组65例。

主要发现

  • 术后并发症(血肿、出血、渗血或水肿)发生率两组无显著差异(2.2% vs 4.6%,P=0.6433)。
  • 支架血管成形术相关医疗器械与药物成本4F组为€1,609.10,6F及以上组为€2,102(P=0.03248)。
  • 6F及以上组额外成本为€492.90,部分归因于动脉闭合装置。

临床怎么用

  • 在外周动脉疾病血管成形术中,可优先考虑使用4F兼容材料以降低器械与药物成本,同时保持与标准鞘管相当的安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To compare the safety and cost of 4-French compatible materials to the standard size (6-French or larger). METHODS: A retrospective analysis was conducted on 2 patient groups stratified by the sheath size used during the intervention. The primary outcome was cost; the secondary outcome was safety, defined as the occurrence of postoperative hematoma, bleeding, oozing, or edema. RESULTS: A total of 110 patients met the inclusion criteria: 45 in the 4F group and 65 in the 6F or larger group. The incidence of postoperative complications was not significantly different between the 2 group (2.2% vs. 4.6%, P = 0.6433). The cost related to medical devices and medication for an angioplasty with stent was estimated at €1,609.10 for the 4F group and €2,102 for the 6F group or larger (P = 0.03248), resulting in an additional cost of €492.90 for the group using 6F or larger sheath, partly due to arterial closure devices. CONCLUSION: Angioplasty using 4F-compatible endovascular materials is as safe as the standard technique with 6F or larger devices, while being more cost-effective.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Donain M, Freyermuth M, Lefebvre M, et al. 4-French Compatible Endovascular Materials for Peripheral Artery Disease: Access Site Complications and Cost Evaluation. Ann Vasc Surg. 2025. PMID: 41177450. doi:10.1016/j.avsg.2025.10.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。